Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Page 1
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE Study.
Häge A, Man KKC, Inglis SK, Buitelaar J, Carucci S, Danckaerts M, Dittmann RW, Falissard B, Garas P, Hollis C, Konrad K, Kovshoff H, Liddle E, McCarthy S, Neubert A, Nagy P, Rosenthal E, Sonuga-Barke EJS, Zuddas A, Wong ICK, Coghill D, Banaschewski T. Häge A, et al. Among authors: falissard b. J Atten Disord. 2024 Mar;28(5):699-707. doi: 10.1177/10870547241232337. Epub 2024 Feb 22. J Atten Disord. 2024. PMID: 38389266
However, data on long-term effects of MPH on sleep remain limited. METHODS: We performed a 2-year naturalistic prospective pharmacovigilance multicentre study. ...CONCLUSION: Our findings support that sleep-problems are common in ADHD, but don't suggest significant negativ …
However, data on long-term effects of MPH on sleep remain limited. METHODS: We performed a 2-year naturalistic prospective pharmacovi …
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) Project.
Carucci S, Zuddas A, Lampis A, Man KKC, Balia C, Buitelaar J, Danckaerts M, Dittmann RW, Donno F, Falissard B, Gagliano A, Garas P, Häge A, Hollis C, Inglis SK, Konrad K, Kovshoff H, Liddle E, McCarthy S, Neubert A, Nagy P, Rosenthal E, Sonuga-Barke EJS, Wong ICK, Banaschewski T, Coghill D. Carucci S, et al. Among authors: falissard b. J Atten Disord. 2024 Mar;28(5):722-739. doi: 10.1177/10870547241226726. Epub 2024 Feb 17. J Atten Disord. 2024. PMID: 38366816
OBJECTIVE: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less clear. ...CONCLUSION: Our results do not suggest safety concerns on long-term treatment with MPH in relation to pubertal maturation an …
OBJECTIVE: The short-term safety of methylphenidate (MPH) has been widely demonstrated; however the long-term safety is less c …
How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients.
Fond G, Falissard B, Nuss P, Collin C, Duret S, Rabbani M, De Chefdebien I, Tonelli I, Llorca PM, Boyer L. Fond G, et al. Among authors: falissard b. Mol Psychiatry. 2023 Dec;28(12):5328-5336. doi: 10.1038/s41380-023-02154-4. Epub 2023 Jul 21. Mol Psychiatry. 2023. PMID: 37479782 Free PMC article.
An important step to improve outcomes for patients with schizophrenia is to understand treatment patterns in routine practice. The aim of the current study was to describe the long-term management of patients with schizophrenia treated with antipsychotics (APs) in real-wor …
An important step to improve outcomes for patients with schizophrenia is to understand treatment patterns in routine practice. The aim of th …
Comparison of Depression and Anxiety Following Self-reported COVID-19-Like Symptoms vs SARS-CoV-2 Seropositivity in France.
Rouquette A, Descarpentry A, Dione F, Falissard B, Legleye S, Vuillermoz C, Pastorello A, Meyer L, Warszawski J, Davisse-Paturet C, Melchior M; EpiCoV Study Group. Rouquette A, et al. Among authors: falissard b. JAMA Netw Open. 2023 May 1;6(5):e2312892. doi: 10.1001/jamanetworkopen.2023.12892. JAMA Netw Open. 2023. PMID: 37166797 Free PMC article.
IMPORTANCE: The long-term consequences of COVID-19 on mental health are a critical issue given the number of people infected with SARS-CoV-2 worldwide since the beginning of the pandemic. ...
IMPORTANCE: The long-term consequences of COVID-19 on mental health are a critical issue given the number of people infected with SAR …
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
Man KKC, Häge A, Banaschewski T, Inglis SK, Buitelaar J, Carucci S, Danckaerts M, Dittmann RW, Falissard B, Garas P, Hollis C, Konrad K, Kovshoff H, Liddle E, McCarthy S, Neubert A, Nagy P, Rosenthal E, Sonuga-Barke EJS, Zuddas A, Wong ICK, Coghill D; ADDUCE Consortium. Man KKC, et al. Among authors: falissard b. Lancet Psychiatry. 2023 May;10(5):323-333. doi: 10.1016/S2215-0366(23)00042-1. Epub 2023 Mar 20. Lancet Psychiatry. 2023. PMID: 36958362
BACKGROUND: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD in children and adolescents in many countries. Although many randomised controlled trials support short-term efficacy, tolerability, and safety, data on long-term safe …
BACKGROUND: Methylphenidate is the most frequently prescribed medication for the treatment of ADHD in children and adolescents in many count …
Long-term methylphenidate exposure and 24-hours blood pressure and left ventricular mass in adolescents and young adults with attention deficit hyperactivity disorder.
Buitelaar JK, van de Loo-Neus GHH, Hennissen L, Greven CU, Hoekstra PJ, Nagy P, Ramos-Quiroga A, Rosenthal E, Kabir S, Man KKC, Ic W, Coghill D; ADDUCE consortium. Buitelaar JK, et al. Eur Neuropsychopharmacol. 2022 Nov;64:63-71. doi: 10.1016/j.euroneuro.2022.09.001. Epub 2022 Oct 7. Eur Neuropsychopharmacol. 2022. PMID: 36209558 Free article.
Young people with attention deficit hyperactivity disorder (ADHD) are now being treated with psychostimulant medication for longer than was previously the case and are increasingly likely to remain on methylphenidate into adolescence and adulthood. This study was designed to dete …
Young people with attention deficit hyperactivity disorder (ADHD) are now being treated with psychostimulant medication for longer than was …
Emotional and attention-deficit/hyperactivity disorder symptoms of preterm vs. full-term children during COVID-19 pandemic restrictions.
Bailhache M, Monnier M, Moulin F, Thierry X, Vandentorren S, Côté SM, Falissard B, Simeon T, Geay B, Marchand L, Dufourg MN, Charles MA, Ancel PY, Melchior M, Rouquette A, Galera C; SAPRIS study group. Bailhache M, et al. Among authors: falissard b. Pediatr Res. 2022 Dec;92(6):1749-1756. doi: 10.1038/s41390-022-02037-4. Epub 2022 Mar 30. Pediatr Res. 2022. PMID: 35354927 Free PMC article.
Our study compared emotional and attention-deficit/hyperactivity disorder (ADHD) symptoms during school closure between preterm and full-term children. METHODS: Data from two French birth cohorts-ELFE and EPIPAGE-2-were used. ...CONCLUSIONS: School closure during lo …
Our study compared emotional and attention-deficit/hyperactivity disorder (ADHD) symptoms during school closure between preterm and full- …
Long-term follow-up of a randomized controlled trial comparing systemic family therapy (FT-S) added to treatment as usual (TAU) with TAU alone in adolescents with anorexia nervosa.
Godart N, Dorard G, Duclos J, Curt F, Kaganski I, Minier L, Corcos M, Falissard B, Eisler I, Jeammet P, Berthoz S. Godart N, et al. Among authors: falissard b. J Child Psychol Psychiatry. 2022 Nov;63(11):1368-1380. doi: 10.1111/jcpp.13583. Epub 2022 Feb 18. J Child Psychol Psychiatry. 2022. PMID: 35178708
BACKGROUND: Randomized controlled trials showed the efficacy of family therapy for anorexia nervosa during adolescence, but studies examining its long-term beneficial effect are still needed. This article presents the results of a 54-month post-randomization follow-up of a …
BACKGROUND: Randomized controlled trials showed the efficacy of family therapy for anorexia nervosa during adolescence, but studies examinin …
Determinants of Inclusion in Mainstream School for Children with Autism Spectrum Disorders from the EpiTED Study: A 10-Year Follow-up Cohort.
Lafont C, Panjo H, Michelon C, Falissard B, Speranza M, Picot MC, Baghdadli A, Rouquette A. Lafont C, et al. Among authors: falissard b. J Autism Dev Disord. 2023 Jan;53(1):121-131. doi: 10.1007/s10803-021-05404-y. Epub 2022 Jan 6. J Autism Dev Disord. 2023. PMID: 34989936
Our objective was to identify clinical and socio-demographic variables promoting or limiting inclusion in mainstream school through childhood and adolescence. The EpiTED study is a long-term, prospective, multicenter cohort of 281 ASD children included before the age of 7, …
Our objective was to identify clinical and socio-demographic variables promoting or limiting inclusion in mainstream school through childhoo …
Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries.
Arango C, Buitelaar JK, Fegert JM, Olivier V, Pénélaud PF, Marx U, Chimits D, Falissard B; study investigators. Arango C, et al. Among authors: falissard b. Lancet Psychiatry. 2022 Feb;9(2):113-124. doi: 10.1016/S2215-0366(21)00390-4. Epub 2021 Dec 14. Lancet Psychiatry. 2022. PMID: 34919834 Clinical Trial.
The melatonin receptor agonist and 5-hydroxytryptamine(2C) receptor antagonist agomelatine is used to treat adults, and could offer a new therapeutic option for paediatric patients. Therefore, we aimed to investigate the short-term antidepressant efficacy and safety of ago …
The melatonin receptor agonist and 5-hydroxytryptamine(2C) receptor antagonist agomelatine is used to treat adults, and could offer a new th …
53 results